News

Thank you for attending today's Beachbody Company, Inc. First Quarter 2025 Earnings Conference Call. My name is Victoria and I will be your moderator for today's call. All lines will be muted during ...
Ignorantia legis neminem excusat. That is, “ignorance of the law is no excuse.” Under this principle, those to whom the law ...
New legislation introduced by Sen. Bill Cassidy (R-La.) seeks to foster more employee-owned US companies by eliminating tax ...
Another gene therapy candidate, OPGx-BEST1, which Opus is developing for treatment of bestrophin-1 (BEST1)-related IRD, is on track to enter the clinic by the fourth quarter of 2025, with preliminary ...